FDA Clearance Tracker · P170027
TherOx Downstream System
Last checked: Nov 20, 2026Latest source record: Apr 2, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Apr 2, 2019
Approved
Time to decision
564 days
Received Sep 15, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P170027
- Device name
- TherOx Downstream System
- Applicant
- Zoll Circulation, Inc.
- Applicant location
- San Jose, CA
- Received
- Sep 15, 2017
- Decided
- Apr 2, 2019
- Decision
- Approved
- Supplements
- 20 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- System, oxygen, aqueous (MWG)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the TherOx Downstream System. This device is indicated for the preparation and delivery of SuperSaturated Oxygen Therapy (SSO2 Therapy) to targeted ischemic regions perfused by the patients left anterior descending coronary artery immediately following revascularization by means of percutaneous coronary intervention (PCI) with stenting that has been completed within 6 hours after the onset of anterior acute myocardial infarction (AMI) symptoms caused by a left anterior descending artery infarct lesion.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code MWG (System, oxygen, aqueous).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Zoll Circulation, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K250979 · Decided Oct 15, 2025 · 198 days after receipt
Device type: Hyperthermia Monitor (NZE) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.